European Archives - Page 8 of 1363 - European Medical Journal

Urinary microRNAs Show Promise for Subtyping of Bladder Cancer

Urinary microRNAs Show Promise for Subtyping of Bladder Cancer

Urinary cell-free microRNAs may enable non-invasive detection of aggressive bladder cancer subtypes, offering a rapid alternative to tissue-based molecular profiling.

Does Air Pollution Accelerate Motor Neuron Disease Progression?

Does Air Pollution Accelerate Motor Neuron Disease Progression?

A nationwide Swedish study links long-term air pollution exposure to increased motor neuron disease risk and poorer outcomes.

Red Blood Cell Immunization Linked to Reduced Survival in MDS

Red Blood Cell Immunization Linked to Reduced Survival in MDS

RBC immunization affects over 14% of transfused patients with myelodysplastic syndromes and is independently associated with markedly reduced survival, highlighting its emerging prognostic relevance.

GLP-1RAs Reduce Asthma Attacks in Adolescents with Obesity

GLP-1RAs Reduce Asthma Attacks in Adolescents with Obesity

Teens with obesity using GLP-1RAs experienced fewer asthma exacerbations, emergency visits, and steroid prescriptions compared with nonpharmacological weight management.

Screens driving horrific harm to children’s health

Screens Driving Horrific Harm to Children’s Health

Doctors warn that screen use and harmful online content may be damaging children’s health, as the UK considers restricting social media access for under-16s.

2L+ ER+/HER2- Metastatic Breast Cancer

This symposium took place during the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The aim of the…

EMJ Oncology 14 [Supplement 1] 2026

The European Society for Medical Oncology (ESMO) Congress 2025 featured important discussions on optimising treatment strategies for…

New Non-Invasive Biomarker for Heart Failure - EMJ

New Non-Invasive Biomarker for Heart Failure

Overexpression of hsa-miR-339-5p suppressed NLRC5, activated the PI3K/Akt signalling pathway, and significantly increased type 1 collagen and α-smooth muscle actin expression, indicating enhanced fibrotic remodelling.

Bimelkizumab Shows Long-term Effectiveness for Psoriasis - EMJ

Evidence Supports Effectiveness of Bimekizumab in Plaque Psoriasis

Real-world data from Italy show high two-year drug survival and sustained disease control with bimekizumab in moderate-to-severe plaque psoriasis.

Mental Disorders And Diabetes Care Disparities - EMJ

Unequal Diabetes Care for People with Mental Disorders

A global meta-analysis shows people with mental disorders receive poorer diabetes monitoring and less access to newer therapies.